A trusted Long on this board PMed me and asked me what my

New Post Public Reply Private Reply Replies (2) Message Board
Mo
587
A trusted Long on this board PMed me and asked me what my opinion was on what delivery mechanism would be used if Brilacidin was chosen to treat symptoms associated with the coronavirus. My guess is that if B is used to minimize coronavirus symptoms that a pill would be the preferred delivery method. If the BDD technology is used for this then BDD could tweak their technology to deliver the payload to wherever it would be best utilized in the digestive tract. IMO serious cases of coronavirus could potentially require an IV to get a stronger dose or perhaps an initial dose directly to the bloodstream. All the above is a guess on my part and is above my pay grade but the point is that IPIX has multiple proven delivery mechanisms for Brilacidin. If the coronavirus continues to spread to pandemic status and IF Brilacidin is found to minimize the symptoms allowing the individual's immune system to fight the virus, I could see widespread use of Brilacidin as a preventative measure. IF that were to happen hold on to you hat as this could be a crazy ride for IPIX investors. There are other posters on this board with a higher science IQ that may have an opinion on this. IPIX has continued to remind investors that their core focus is to advance B-OM and B-IBD to market through partnerships. I view any coronavirus activity as a positive exposure to new investors and confirmation to potential BP partners that Brilacidin has great potential across many instances and markets as a franchise drug. It is very possible though that government funding and grants could advance Brilacidin into a whole new market that was not on our radar until last week. This is an exciting time to be an IPIX investor.

1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 70

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 137

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 116

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 216

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 261

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 111

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 253

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 121

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading

Top 5 Most Recently Viewed Articles

Aethlon Medical Sets Upcoming Financial Call: What to Expect

Updated Category News Views 27

Aethlon Medical Announces Upcoming Financial Results Aethlon Medical, Inc. (NASDAQ: AEMD), a company dedicated to advancements in medical therapeutics, is preparing to release its financial results for the fiscal second quarter. This report will cover the period that concluded on September 30, with the official release set for a specific time on an upcoming Wednesday....

Continue Reading
Community Associations Institute Challenges Corporate Transparency Act

Updated Category News Views 63

Community Associations Institute Files for Preliminary Injunction Today, the United States District Court will hear a legal case involving the Community Associations Institute (CAI) regarding the Corporate Transparency Act. The proceedings are set to begin as CAI seeks to prevent the enforcement of this law against community associations. Understanding the Corporate...

Continue Reading
OMNIQ Corp. Prepares for Its Upcoming Virtual Conference

Updated Category News Views 54

OMNIQ Corp. Set to Showcase Innovations at Upcoming Event OMNIQ Corp. (OMQS), a front-runner in AI-machine vision and automation technology, has announced a significant opportunity for investors. Shai Lustgarten, the CEO of OMNIQ, will present at the Small Cap Virtual Investor Conference, an interactive platform designed for investors to engage directly with public...

Continue Reading
Revolutionizing Orthopedics: Exactech’s Innovative CT Analysis

Updated Category News Views 112

Revolutionizing Pre-Operative Planning with CT Radiomics Exactech, a leader in medical technology, recently introduced an impressive breakthrough in orthopedic surgery: the large-scale, fully automated CT radiomic analysis of shoulder bones and muscles. This pioneering study marks a significant advancement in personalized pre-operative planning for shoulder surgeries....

Continue Reading
Industrial Scientific Launches Advanced MPS LEL Sensor for Safety

Updated Category News Views 85

Industrial Scientific Introduces MPS LEL Sensor The new sensor for the Radius BZ1 enhances runtime, reliability, and the detection of various flammable gases. Significant Advancements in Gas Detection Industrial Scientific, a global leader in automation for safety workflows, has launched the latest generation of MPS™ LEL Sensors. These sensors are integral to their...

Continue Reading